Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-05
2011-07-05
Katakam, Sudhakar (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C562S439000, C562S405000, C562S433000, C560S019000, C560S034000
Reexamination Certificate
active
07973063
ABSTRACT:
Novel biaromatic compounds having the following structural formula (I):are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, in particular in dermatology as well as in the fields of cardiovascular diseases, immune diseases and/or diseases related to the metabolism of lipids, or, alternatively, into cosmetic compositions.
REFERENCES:
patent: 7294639 (2007-11-01), Bernardon et al.
patent: 2003/0134885 (2003-07-01), Bernardon et al.
patent: 2004/0039038 (2004-02-01), Bernardon et al.
patent: WO 0212210 (2002-02-01), None
patent: WO 2004048351 (2004-06-01), None
International Search Report for corresponding PCT/EP2005/005797 dated Jul. 21, 2005, 3 pages.
STN Caplus Abstract, Accession No. 2004:432769, Document No. 140:429035.
International Search Report for corresponding PCT/EP2005/005797 dated Jul. 21, 2005, 3 pages.
Aubert Jerome
Boiteau Jean-Guy
Clary Laurence
Mauvais Pascale
Rivier Michel
Buchanan Ingersoll & Rooney P.C.
Galderma Research & Development
Katakam Sudhakar
LandOfFree
Methods for activating PPAR gamma-type receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for activating PPAR gamma-type receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for activating PPAR gamma-type receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2667933